As we move through Spring 2026, women’s healthcare services across the UK continue to evolve in response to changing clinical demands, workforce pressures, and national healthcare priorities. AGHealth remain committed to supporting NHS teams with innovative diagnostics, induction solutions, and clinical implementation support designed to improve patient experience and operational efficiency. In this edition, we explore: The ongoing national Prostin shortage Latest development

Snowsill et al.; Cost-minimisation analysis of the WID-qEC epigenetic biomarker compared to transvaginal ultrasound for triaging abnormal uterine bleeding. Value in Health, 2026 A newly peer-reviewed cost-minimisation analysis published in Value in Health demonstrates that WID-easy offers a compelling economic and clinical alternative to transvaginal ultrasound (TVUS) as the first-line triage test for patients presenting with abnormal uterine bleeding (AUB) referred to the Ur